Nektar Therapeutics (NKTR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 1,193,323 | 307,711 | 165,436 | 230,784 | 200,707 |
| Cost of Goods | 24,412 | 30,547 | 30,215 | 34,102 | 28,533 |
| Gross Profit | 1,168,911 | 277,164 | 135,221 | 196,682 | 172,174 |
| Operating Expenses | 481,391 | 337,353 | 248,291 | 226,155 | 189,192 |
| Operating Income | 687,932 | -59,642 | -112,855 | -29,371 | -16,485 |
| Interest Expense | 42,778 | 40,954 | 42,180 | 38,901 | 38,757 |
| Other Income | 37,571 | 4,520 | 2,387 | -12,399 | 814 |
| Pre-tax Income | 682,725 | -96,076 | -152,648 | -80,671 | -54,428 |
| Income Tax | 1,412 | 616 | 876 | 506 | -512 |
| Net Income Continuous | 681,313 | -96,692 | -153,524 | -81,177 | -53,916 |
| Net Income | $681,313 | $-96,692 | $-153,524 | $-81,177 | $-53,916 |
| EPS Basic Total Ops | 4.02 | -0.62 | -1.10 | -0.61 | -0.42 |
| EPS Basic Continuous Ops | 4.02 | -0.62 | -1.10 | -0.61 | -0.43 |
| EPS Diluted Total Ops | 3.78 | -0.62 | -1.10 | -0.61 | -0.42 |
| EPS Diluted Continuous Ops | 3.78 | -0.62 | -1.10 | -0.61 | -0.43 |
| EPS Diluted Before Non-Recurring Items | 3.78 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $698,802 | $-44,901 | $-97,504 | $-16,516 | $-3,558 |